The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
He holds a Master’s in Management from the National University of Singapore
Potential of Ayurveda’s contribution in global health system through various innovative practices
India has taken the lead in recognising NAFLD as a major non-communicable disease
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
Subscribe To Our Newsletter & Stay Updated
